Last visit was: 03 Sep 2026, 06:45 It is currently 03 Sep 2026, 06:45
Close
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Close
Request Expert Reply
Confirm Cancel
User avatar
DealMakerOne
Joined: 01 Jan 2017
Last visit: 08 Oct 2021
Posts: 58
Own Kudos:
236
 [8]
Given Kudos: 76
WE:General Management (Consulting)
Posts: 58
Kudos: 236
 [8]
1
Kudos
Add Kudos
7
Bookmarks
Bookmark this Post
Most Helpful Reply
avatar
AUTricco27
Joined: 15 Apr 2019
Last visit: 12 Nov 2019
Posts: 9
Own Kudos:
6
 [5]
Given Kudos: 42
Posts: 9
Kudos: 6
 [5]
4
Kudos
Add Kudos
1
Bookmarks
Bookmark this Post
General Discussion
User avatar
durant25
Joined: 21 Jan 2026
Last visit: 31 Aug 2026
Posts: 21
Own Kudos:
Given Kudos: 222
Posts: 21
Kudos: 1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
User avatar
guddo
Joined: 25 May 2021
Last visit: 02 Sep 2026
Posts: 1,816
Own Kudos:
14,336
 [1]
Given Kudos: 32
Posts: 1,816
Kudos: 14,336
 [1]
1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
When prescribing a medication, doctors have to compare the positive effect of the medication against any complications it may cause, because treatment benefits must exceed treatment risks. However, when treating koliroma, most doctors should just prescribe the medicine that has the strongest positive effect.

Which of the following, if true, best supports the recommendation for doctors treating koliroma?


The general rule is that doctors must compare benefits with risks. The recommendation says that, for koliroma, doctors should focus only on the medication’s positive effect. The best support would show that the risk side is the same for all koliroma medications. Then the strongest positive effect would also give the best overall benefit-risk result.

(A) Koliroma is a very rare disease that can be detected only through special laboratory blood tests.

This is irrelevant. Rarity and detection method do not show that doctors should choose the strongest medication.

(B) Some medications against koliroma cause serious side effects that can lead to even more severe health problems.

This weakens the recommendation. If side effects differ and can be serious, doctors should not simply choose the strongest medication.

(C) Unlike many other diseases, koliroma is not likely to cause any complications if it is properly treated.

This does not compare the medications’ risks. The issue is not whether treated koliroma causes complications, but whether the medications have different risks.

(D) Detecting koliroma does not involve any medications that could cause long-term negative effects on patients’ health.

This is irrelevant. The argument is about treating koliroma, not detecting it.

(E) All medications used for koliroma have the same negative effects.

This is correct. If all koliroma medications have the same negative effects, then the risk side is equal. So doctors can choose based on the positive effect, and the medicine with the strongest positive effect is the best choice.

Answer: (E)
Moderators:
GMAT Club Verbal Expert
7399 posts
Verbal Forum Moderator
705 posts